Literature DB >> 22427576

Recessive mutations in TSPAN12 cause retinal dysplasia and severe familial exudative vitreoretinopathy (FEVR).

James A Poulter1, Alice E Davidson, Manir Ali, David F Gilmour, David A Parry, Helen A Mintz-Hittner, Ian M Carr, Helen M Bottomley, Vernon W Long, Louise M Downey, Panagiotis I Sergouniotis, Genevieve A Wright, Robert E MacLaren, Anthony T Moore, Andrew R Webster, Chris F Inglehearn, Carmel Toomes.   

Abstract

PURPOSE: Familial exudative vitreoretinopathy (FEVR) is an inherited disorder that disrupts the development of the retinal vasculature and can result in blindness. FEVR is genetically heterogeneous and mutations in four genes, NDP, FZD4, LRP5, and TSPAN12, encoding components of a novel ligand-receptor complex that activates the Norrin-β-catenin signaling pathway, account for approximately 50% of cases. We recently identified mutations in TSPAN12 as a cause of dominant FEVR. The purpose of this study was to identify recessive TSPAN12 mutations in FEVR patients.
METHODS: Mutation screening was performed by directly sequencing PCR products generated from genomic DNA with primers designed to amplify the coding sequence of TSPAN12. Splicing defects were verified by reverse transcriptase PCR of leukocyte cDNA.
RESULTS: TSPAN12 screening in a large dominant FEVR family unexpectedly led to the identification of homozygous mutations in severely affected family members, whereas mildly affected family members were heterozygous. Further screening in a cohort of 10 retinal dysplasia/severe FEVR patients identified an additional three cases with recessive TSPAN12 mutations. In all examined cases, single mutation carriers were mildly affected compared to patients harboring two TSPAN12 mutations.
CONCLUSIONS: We report for the first time recessive mutations in TSPAN12 and describe the first genetic cause for the clinical variation seen in FEVR families. Our data raise the possibility that patients with severe FEVR actually may harbor two mutant alleles, derived either from the same gene or potentially from other genes encoding components of the Norrin-β-catenin signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22427576     DOI: 10.1167/iovs.11-8629

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  27 in total

Review 1.  Frizzled Receptors in Development and Disease.

Authors:  Yanshu Wang; Hao Chang; Amir Rattner; Jeremy Nathans
Journal:  Curr Top Dev Biol       Date:  2016-01-27       Impact factor: 4.897

2.  TSPAN12 Is a Norrin Co-receptor that Amplifies Frizzled4 Ligand Selectivity and Signaling.

Authors:  Maria B Lai; Chi Zhang; Jianli Shi; Verity Johnson; Lavan Khandan; John McVey; Michael W Klymkowsky; Zhe Chen; Harald J Junge
Journal:  Cell Rep       Date:  2017-06-27       Impact factor: 9.423

3.  The role of the hypoxia response in shaping retinal vascular development in the absence of Norrin/Frizzled4 signaling.

Authors:  Amir Rattner; Yanshu Wang; Yulian Zhou; John Williams; Jeremy Nathans
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-11-20       Impact factor: 4.799

Review 4.  Familial exudative vitreoretinopathy and related retinopathies.

Authors:  D F Gilmour
Journal:  Eye (Lond)       Date:  2014-10-17       Impact factor: 3.775

5.  Genotype-phenotype associations in familial exudative vitreoretinopathy: A systematic review and meta-analysis on more than 3200 individuals.

Authors:  Xiaona Wang; Jun Chen; Hui Xiong; Xuhui Yu
Journal:  PLoS One       Date:  2022-07-13       Impact factor: 3.752

6.  Canonical WNT signaling components in vascular development and barrier formation.

Authors:  Yulian Zhou; Yanshu Wang; Max Tischfield; John Williams; Philip M Smallwood; Amir Rattner; Makoto M Taketo; Jeremy Nathans
Journal:  J Clin Invest       Date:  2014-08-01       Impact factor: 14.808

7.  Defects in the Cell Signaling Mediator β-Catenin Cause the Retinal Vascular Condition FEVR.

Authors:  Evangelia S Panagiotou; Carla Sanjurjo Soriano; James A Poulter; Emma C Lord; Denisa Dzulova; Hiroyuki Kondo; Atsushi Hiyoshi; Brian Hon-Yin Chung; Yoyo Wing-Yiu Chu; Connie H Y Lai; Mark E Tafoya; Dyah Karjosukarso; Rob W J Collin; Joanne Topping; Louise M Downey; Manir Ali; Chris F Inglehearn; Carmel Toomes
Journal:  Am J Hum Genet       Date:  2017-06-01       Impact factor: 11.025

8.  Pathogenic variants and associated phenotypic spectrum of TSPAN12 based on data from a large cohort.

Authors:  Wenmin Sun; Xueshan Xiao; Shiqiang Li; Xiaoyun Jia; Panfeng Wang; Qingjiong Zhang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-04-27       Impact factor: 3.117

9.  Identification of two novel LRP5 mutations in families with familial exudative vitreoretinopathy.

Authors:  Ping Fei; Qi Zhang; Luling Huang; Yu Xu; Xiong Zhu; Zhengfu Tai; Bo Gong; Shi Ma; Quanyao Yao; Jing Li; Peiquan Zhao; Zhenglin Yang
Journal:  Mol Vis       Date:  2014-03-29       Impact factor: 2.367

10.  A secreted WNT-ligand-binding domain of FZD5 generated by a frameshift mutation causes autosomal dominant coloboma.

Authors:  Chunqiao Liu; Sonya A Widen; Kathleen A Williamson; Rinki Ratnapriya; Christina Gerth-Kahlert; Joe Rainger; Ramakrishna P Alur; Erin Strachan; Souparnika H Manjunath; Archana Balakrishnan; James A Floyd; Tiansen Li; Andrew Waskiewicz; Brian P Brooks; Ordan J Lehmann; David R FitzPatrick; Anand Swaroop
Journal:  Hum Mol Genet       Date:  2016-01-24       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.